<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Islam MS</submitter><funding>NIGMS NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | National Institutes of Health</funding><funding>NIH HHS</funding><pagination>350</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8763920</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>We report the discovery of a facile peptide macrocyclization and stapling strategy based on a fluorine thiol displacement reaction (FTDR), which renders a class of peptide analogues with enhanced stability, affinity, cellular uptake, and inhibition of cancer cells. This approach enabled selective modification of the orthogonal fluoroacetamide side chains in unprotected peptides in the presence of intrinsic cysteines. The identified benzenedimethanethiol linker greatly promoted the alpha helicity of a variety of peptide substrates, as corroborated by molecular dynamics simulations. The cellular uptake of benzenedimethanethiol stapled peptides appeared to be universally enhanced compared to the classic ring-closing metathesis (RCM) stapled peptides. Pilot mechanism studies suggested that the</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Unprotected peptide macrocyclization and stapling via a fluorine-thiol displacement reaction.</pubmed_title><pmcid>PMC8763920</pmcid><funding_grant_id>R01 GM116204</funding_grant_id><funding_grant_id>R01GM116204</funding_grant_id><funding_grant_id>R35GM22552</funding_grant_id><funding_grant_id>R35 GM133468</funding_grant_id><funding_grant_id>S10 OD020095</funding_grant_id><funding_grant_id>R35GM133468</funding_grant_id><funding_grant_id>R01 GM123296</funding_grant_id><funding_grant_id>R01GM123296</funding_grant_id><pubmed_authors>Kafley P</pubmed_authors><pubmed_authors>Kaneria KH</pubmed_authors><pubmed_authors>Lyu Z</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Maloney R</pubmed_authors><pubmed_authors>Voelz VA</pubmed_authors><pubmed_authors>Islam MS</pubmed_authors><pubmed_authors>Junod SL</pubmed_authors><pubmed_authors>Yang W</pubmed_authors><pubmed_authors>Wang RE</pubmed_authors><pubmed_authors>Guan Y</pubmed_authors><pubmed_authors>Zhao M</pubmed_authors><pubmed_authors>Buuh ZY</pubmed_authors><pubmed_authors>Cohen C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Unprotected peptide macrocyclization and stapling via a fluorine-thiol displacement reaction.</name><description>We report the discovery of a facile peptide macrocyclization and stapling strategy based on a fluorine thiol displacement reaction (FTDR), which renders a class of peptide analogues with enhanced stability, affinity, cellular uptake, and inhibition of cancer cells. This approach enabled selective modification of the orthogonal fluoroacetamide side chains in unprotected peptides in the presence of intrinsic cysteines. The identified benzenedimethanethiol linker greatly promoted the alpha helicity of a variety of peptide substrates, as corroborated by molecular dynamics simulations. The cellular uptake of benzenedimethanethiol stapled peptides appeared to be universally enhanced compared to the classic ring-closing metathesis (RCM) stapled peptides. Pilot mechanism studies suggested that the</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2026-05-07T22:20:45.74Z</modification><creation>2025-02-19T03:53:30.886Z</creation></dates><accession>S-EPMC8763920</accession><cross_references><pubmed>35039490</pubmed><doi>10.1038/s41467-022-27995-5</doi></cross_references></HashMap>